Skip to main content
Clinical Trials/DRKS00033322
DRKS00033322
Completed
Not Applicable

Prospective evaluation of an artificial intelligence (AI)-assisted, software-based (Quantib®Prostate) reporting of multiparametric magnetic resonance imaging (MRI) in the context of MRI/ultrasound fusion biopsies of the prostate

Vivantes Klinikum Am Urban0 sites262 target enrollmentDecember 29, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C61
Sponsor
Vivantes Klinikum Am Urban
Enrollment
262
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 29, 2023
End Date
August 31, 2022
Last Updated
last year
Study Type
Observational
Sex
Male

Investigators

Sponsor
Vivantes Klinikum Am Urban

Eligibility Criteria

Inclusion Criteria

  • patients with an mpMRI of the prostate (T2, DWI and, if applicable, DCE sequences) who are suitable for evaluation with the Quantib®Prostate AI software and who subsequently undergo an MRI/US fusion biopsy of the prostate with needle tracking at the urology clinic of Vivantes Klinikum Am Urban.

Exclusion Criteria

  • \- inadequate image quality of the mpMRI
  • \- missing mpMRI before biopsy
  • \- missing mpMRI sequences for analysis by the AI software
  • \- premature termination of the prostate biopsy or insufficient histological material for subsequent analyses

Outcomes

Primary Outcomes

Not specified

Similar Trials